Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications, J Bone Miner Res, vol.24, issue.4, pp.702-711, 2009. ,
Insights into bone fragility in diabetes: the crucial role of bone quality on skeletal strength, Endocr J, vol.62, issue.4, pp.299-308, 2015. ,
Advanced glycation end products, diabetes, and bone strength, Curr Osteoporos Rep, vol.14, issue.6, pp.320-326, 2016. ,
Effect of type 2 diabetes-related non-enzymatic glycation on bone biomechanical properties, Bone, vol.82, pp.21-28, 2016. ,
Mechanisms of diabetes mellitus-induced bone fragility, Nat Rev Endocrinol, vol.13, issue.4, pp.208-227, 2017. ,
Glucagon-like peptide-1 receptors in the brain: controlling food intake and body weight, J Clin Invest, vol.124, issue.10, pp.4223-4229, 2014. ,
GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia, J Endocrinol, vol.209, issue.2, pp.203-213, 2011. ,
Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states, Regul Pept, issue.1-3, pp.61-67, 2010. ,
Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes, Life Sci, vol.92, issue.10, pp.533-573, 2013. ,
Liraglutide, the glucagon-like peptide-1 receptor agonist, has anabolic bone effects in diabetic Goto-Kakizaki rats, J Diabetes, vol.7, issue.4, pp.584-592, 2015. ,
Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats, J Bone Miner Res, vol.28, issue.7, pp.1641-52, 2013. ,
Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor, J Endocrinol, vol.219, issue.1, pp.59-68, 2013. ,
Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength, Osteoporos Int, vol.26, issue.1, pp.209-227, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01392271
Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice, Bone, vol.81, pp.459-67, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01567148
The key role of the blood supply to bone, Bone Res, vol.1, issue.3, pp.203-218, 2013. ,
Effect of age on vascularization during fracture repair, J Orthop Res, vol.26, issue.10, pp.1384-1393, 2008. ,
Reduced bone perfusion in osteoporosis: likely causes in an ovariectomy rat model, Radiology, vol.254, issue.3, pp.739-785, 2010. ,
Vascular complications in diabetes mellitus: the role of endothelial dysfunction, Clin Sci, vol.109, issue.2, pp.143-59, 2005. ,
The cardiovascular effects of GLP-1 receptor agonists, Cardiovasc Ther, vol.30, issue.3, pp.146-55, 2012. ,
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease, Am J Physiol Endocrinol Metab, vol.287, issue.6, pp.1209-1224, 2004. ,
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways, Circulation, vol.117, issue.18, pp.2340-50, 2008. ,
Skeletal phenotype of the leptin receptor-deficient db/db mouse, J Bone Miner Res, vol.26, issue.8, pp.1698-709, 2011. ,
Quantitative analysis of pancreatic proinsulin mRNA in genetically diabetic (db/db) mice, Diabetes, vol.36, issue.3, pp.341-348, 1987. ,
Bone abnormalities in adolescent leptin-deficient mice, Regul Pept, vol.136, issue.1-3, pp.9-13, 2006. ,
A new stable GIP-oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus, Bone, vol.87, pp.102-115, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01392261
In the clinic. Type 2 diabetes, Ann Intern Med, issue.5, pp.31-46, 2010. ,
Validated laser Doppler protocol for measurement of mouse bone blood perfusion-response to age or ovariectomy differs with genetic background, Bone, vol.55, issue.2, pp.418-444, 2013. ,
URL : https://hal.archives-ouvertes.fr/ujm-00962139
Guidelines for assessment of bone microstructure in rodents using micro-computed tomography, J Bone Miner Res, issue.7, pp.1468-86, 2010. ,
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee, J Bone Miner Res, vol.28, issue.1, pp.2-17, 2013. ,
Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties, Bone, vol.63, pp.61-69, 2014. ,
FTIR microspectroscopic analysis of human osteonal bone, Calcif Tissue Int, vol.59, issue.6, pp.480-487, 1996. ,
Rat osteoblast cultures, Methods Mol Biol, vol.816, pp.31-41, 2012. ,
Three-dimensional methods for quantification of cancellous bone architecture, Bone, vol.20, issue.4, pp.315-343, 1997. ,
Leptin and the regulation of body weight in mammals, Nature, vol.395, issue.6704, pp.763-70, 1998. ,
Obesity and type 2 diabetes: what can be unified and what needs to be individualized? Diabetes Care, vol.34, pp.1424-1454, 2011. ,
Increased obese mRNA expression in omental fat cells from massively obese humans, Nat Med, vol.1, issue.9, pp.953-959, 1995. ,
Evidence that the diabetes gene encodes the leptin receptor: identification of a mutation in the leptin receptor gene in db/db mice, Cell, vol.84, issue.3, pp.81294-81299, 1996. ,
Identification and expression cloning of a leptin receptor, OB-R. Cell, vol.83, issue.7, pp.1263-71, 1995. ,
Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice, Diabetologia, vol.14, issue.3, pp.141-149, 1978. ,
Abnormalities of GIP in spontaneous syndromes of obesity and diabetes in mice, Diabetes, vol.32, issue.5, pp.433-438, 1983. ,
Leptin functions peripherally to regulate differentiation of mesenchymal progenitor cells, Stem Cells, issue.6, pp.1071-80, 2010. ,
The role of leptin in regulating bone metabolism, Metabolism, vol.64, issue.1, pp.105-118, 2015. ,
Exenatide once weekly: a review of pharmacology and treatment considerations in type 2 diabetes, Clin Ther, vol.38, issue.3, pp.582-94, 2016. ,
GLP-1 receptor activation modulates appetite-and reward-related brain areas in humans, Diabetes, vol.63, issue.12, pp.4186-96, 2014. ,
Leptin receptor deficient diabetic (db/db) mice are compromised in postnatal bone regeneration, Cell Tissue Res, vol.356, issue.1, pp.195-206, 2014. ,
Effect of glucagon-like peptide-1 on the differentiation of adipose-derived stem cells into osteoblasts and adipocytes, J Menopausal Med, vol.21, issue.2, pp.93-103, 2015. ,
Glucose-induced inhibition of in vitro bone mineralization, Bone, vol.28, issue.1, pp.426-435, 2001. ,
Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus, Osteoporos Int, vol.28, issue.1, pp.309-329, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01567142
Liraglutide, a glucagon-like peptide-1 receptor agonist, facilitates osteogenic proliferation and differentiation in MC3T3-E1 cells through phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT), extracellular signal-related kinase (ERK)1/2, and cAMP/protein kinase A (PKA) signaling pathways involving beta-catenin, Exp Cell Res, vol.360, issue.2, pp.281-91, 2017. ,
Exendin-4 promotes proliferation and differentiation of MC3T3-E1 osteoblasts by MAPKs activation, J Mol Endocrinol, vol.56, issue.3, pp.189-99, 2016. ,
Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor, J Cell Physiol, vol.225, issue.2, pp.585-92, 2010. ,
Liraglutide attenuates the osteoblastic differentiation of MC3T3E1 cells by modulating AMPK/mTOR signaling, Mol Med Rep, vol.14, issue.4, pp.3662-3670, 2016. ,
Expression of glucagon-like peptide-1 receptor and glucose-dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells, Int J Mol Med, vol.34, issue.2, pp.475-82, 2014. ,
The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism, J Transl Med, vol.14, issue.1, p.229, 2016. ,
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management, JAMA, vol.287, pp.2570-81, 2002. ,
Microspheres accurately predict regional bone blood flow, Clin Orthop Relat Res, vol.424, pp.253-65, 2004. ,
Evaluation of laser-Doppler perfusion imaging for measurement of blood flow in cortical bone, J Appl Physiol, vol.90, issue.4, pp.1314-1322, 2001. ,
Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat, J Endocrinol, vol.225, issue.1, pp.47-58, 2015. ,
Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism, Regul Pept, vol.125, issue.1-3, pp.173-180, 2005. ,
Exenatide induces aortic vasodilation increasing hydrogen sulphide, carbon monoxide and nitric oxide production, Cardiovasc Diabetol, vol.13, p.69, 2014. ,
GLP-1 receptor agonist exenatide increases capillary perfusion independent of nitric oxide in healthy overweight men, Arterioscler Thromb Vasc Biol, vol.35, issue.6, pp.1538-1581, 2015. ,
Intermittent PTH(1-84) is osteoanabolic but not osteoangiogenic and relocates bone marrow blood vessels closer to bone-forming sites, J Bone Miner Res, vol.26, issue.11, pp.2583-96, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01825245
Compromised bone marrow perfusion in osteoporosis, J Bone Miner Res, vol.23, issue.7, pp.1068-75, 2008. ,
Gender difference in response predictors after 1-year exenatide therapy twice daily in type 2 diabetic patients: a real world experience, Diabetes Metab Syndr Obes, vol.6, pp.123-132, 2013. ,
Sex and estrogens alter the action of glucagon-like peptide-1 on reward, Biol Sex Differ, vol.7, p.6, 2016. ,